Literature DB >> 24243010

T cell susceptibility to HIV influences outcome of opportunistic infections.

Kapil K Saharia1, Richard A Koup.   

Abstract

During HIV infection, the timing of opportunistic infections is not always associated with severity of CD4 T cell depletion, and different opportunistic pathogens reactivate at different CD4 T cell thresholds. Here, we examine how differences in the phenotype and function of pathogen-specific CD4 T cells influence susceptibility to HIV infection. By focusing on three common opportunistic infections (Mycobacterium tuberculosis, human papillomavirus, and cytomegalovirus), we investigate how differential depletion of pathogen-specific CD4 T cells impacts the natural history of these pathogens in HIV infection. A broader understanding of this relationship can better inform treatment strategies against copathogens.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24243010      PMCID: PMC3858849          DOI: 10.1016/j.cell.2013.09.045

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  119 in total

1.  Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus.

Authors:  Martina Sester; Urban Sester; Barbara Gärtner; Boris Kubuschok; Matthias Girndt; Andreas Meyerhans; Hans Köhler
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.

Authors:  K V Komanduri; S M Donahoe; W J Moretto; D K Schmidt; G Gillespie; G S Ogg; M Roederer; D F Nixon; J M McCune
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

3.  Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.

Authors:  M A Jacobson; R Schrier; J M McCune; F J Torriani; G N Holland; J J O'Donnell; W R Freeman; B M Bredt
Journal:  J Infect Dis       Date:  2001-03-30       Impact factor: 5.226

4.  Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.

Authors:  Y Yazdanpanah; G Chêne; E Losina; S J Goldie; L D Merchadou; S Alfandari; G R Seage; L Sullivan; C Marimoutou; A D Paltiel; R Salamon; Y Mouton; K A Freedberg
Journal:  Int J Epidemiol       Date:  2001-08       Impact factor: 7.196

5.  Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens.

Authors:  M Nakagawa; D P Stites; S Patel; S Farhat; M Scott; N K Hills; J M Palefsky; A B Moscicki
Journal:  J Infect Dis       Date:  2000-07-28       Impact factor: 5.226

6.  Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide.

Authors:  Anna S Kadish; Patrick Timmins; Yuexian Wang; Gloria Y F Ho; Robert D Burk; John Ketz; Wu He; Seymour L Romney; Anne Johnson; Ruth Angeletti; Maria Abadi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-05       Impact factor: 4.254

7.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study.

Authors:  R J Wilkinson; M Llewelyn; Z Toossi; P Patel; G Pasvol; A Lalvani; D Wright; M Latif; R N Davidson
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

8.  CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.

Authors:  Samantha R Slight; Javier Rangel-Moreno; Radha Gopal; Yinyao Lin; Beth A Fallert Junecko; Smriti Mehra; Moises Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Lenin Pavon; Deepak Kaushal; Todd A Reinhart; Troy D Randall; Shabaana A Khader
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

9.  CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria.

Authors:  Frank Heuts; Dolores Gavier-Widén; Berit Carow; Julius Juarez; Hans Wigzell; Martin E Rottenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-04       Impact factor: 11.205

10.  The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice.

Authors:  T Mogues; M E Goodrich; L Ryan; R LaCourse; R J North
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  21 in total

1.  Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization.

Authors:  Valentina Cecchinato; Enos Bernasconi; Roberto F Speck; Michele Proietti; Ulrike Sauermann; Gianluca D'Agostino; Gabriela Danelon; Tanja Rezzonico Jost; Fabio Grassi; Lorenzo Raeli; Franziska Schöni-Affolter; Christiane Stahl-Hennig; Mariagrazia Uguccioni
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

2.  Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype.

Authors:  Catherine Riou; Ramla F Tanko; Andreia P Soares; Lindi Masson; Lise Werner; Nigel J Garrett; Natasha Samsunder; Quarraisha Abdool Karim; Salim S Abdool Karim; Wendy A Burgers
Journal:  J Immunol       Date:  2015-07-20       Impact factor: 5.422

3.  HIV-1 Infection Is Associated with Depletion and Functional Impairment of Mycobacterium tuberculosis-Specific CD4 T Cells in Individuals with Latent Tuberculosis Infection.

Authors:  Cheryl L Day; Deborah A Abrahams; Levelle D Harris; Michele van Rooyen; Lynnett Stone; Marwou de Kock; Willem A Hanekom
Journal:  J Immunol       Date:  2017-07-31       Impact factor: 5.422

Review 4.  Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy.

Authors:  Yuqi Zhou; Colby R Maldini; Julie Jadlowsky; James L Riley
Journal:  J Infect Dis       Date:  2021-02-15       Impact factor: 5.226

5.  Predictive factors for the Nursing Diagnoses in people living with Acquired Immune Deficiency Syndrome.

Authors:  Richardson Augusto Rosendo da Silva; Romanniny Hévillyn Silva Costa; Ana Raquel Cortês Nelson; Fernando Hiago da Silva Duarte; Nanete Caroline da Costa Prado; Eduardo Henrique Fagundes Rodrigues
Journal:  Rev Lat Am Enfermagem       Date:  2016-07-04

6.  Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell Responses.

Authors:  Lyle W Murray; Iman Satti; Jodi Meyerowitz; Matthew Jones; Christian B Willberg; James E Ussher; Dominique Goedhals; Jacob Hurst; Rodney E Phillips; Helen McShane; Cloete van Vuuren; John Frater
Journal:  J Infect Dis       Date:  2018-05-05       Impact factor: 5.226

7.  A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study.

Authors:  Ziqi Wang; Li Yang; Yi Chen; Zhiwei Xu; Hui Wang; Xiaoju Zhang
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

8.  Epigenetic Mechanisms Underlying HIV-Infection Induced Susceptibility of CD4+ T Cells to Enhanced Activation-Induced FasL Expression and Cell Death.

Authors:  Smita S Ghare; Paula M Chilton; Aakarsha V Rao; Swati Joshi-Barve; Paula Peyrani; Andrea Reyes Vega; Craig J McClain; Kendall Bryant; Robert L Cook; Mathew Freiberg; Shirish Barve
Journal:  J Acquir Immune Defic Syndr       Date:  2021-01-01       Impact factor: 3.771

Review 9.  HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide.

Authors:  Maria Theresa Montales; Arun Chaudhury; Alexandria Beebe; Sowmya Patil; Naveen Patil
Journal:  Front Public Health       Date:  2015-12-23

10.  Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection.

Authors:  Fengliang Liu; Xiuzhen Fan; Sarah Auclair; Monique Ferguson; Jiaren Sun; Lynn Soong; Wei Hou; Robert R Redfield; Deborah L Birx; Silvia Ratto-Kim; Merlin L Robb; Jerome H Kim; Nelson L Michael; Haitao Hu
Journal:  PLoS Pathog       Date:  2016-06-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.